Vascular Resections During the Whipple Procedure

Pancreatic ductal adenocarcinoma (PDA) remains a formidable challenge for surgeons and oncologists alike. Overall, 5-year survival rates remain less than 5% for patients with such cancers. Currently the third leading cause of cancer death in America, it is predicted that by 2020 to 2030 PDA will become the second leading cause of cancer-related deaths in the United States. Combination chemotherapy regimens, such as gemcitabine plus albumin-bound...